Sedana Medical AB (SEDANA) - Net Assets

Latest as of December 2025: Skr900.78 Million SEK ≈ $96.94 Million USD

Based on the latest financial reports, Sedana Medical AB (SEDANA) has net assets worth Skr900.78 Million SEK (≈ $96.94 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr954.46 Million ≈ $102.72 Million USD) and total liabilities (Skr53.68 Million ≈ $5.78 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check asset resilience ratio of Sedana Medical AB to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets Skr900.78 Million
% of Total Assets 94.38%
Annual Growth Rate 113.94%
5-Year Change -18.22%
10-Year Change 71277.26%
Growth Volatility 2721.09

Sedana Medical AB - Net Assets Trend (2015–2025)

This chart illustrates how Sedana Medical AB's net assets have evolved over time, based on quarterly financial data. Also explore SEDANA total assets for the complete picture of this company's asset base.

Annual Net Assets for Sedana Medical AB (2015–2025)

The table below shows the annual net assets of Sedana Medical AB from 2015 to 2025. For live valuation and market cap data, see market value of Sedana Medical AB.

Year Net Assets Change
2025-12-31 Skr900.78 Million
≈ $96.94 Million		 -6.00%
2024-12-31 Skr958.23 Million
≈ $103.12 Million		 -1.21%
2023-12-31 Skr970.00 Million
≈ $104.39 Million		 -5.75%
2022-12-31 Skr1.03 Billion
≈ $110.75 Million		 -6.56%
2021-12-31 Skr1.10 Billion
≈ $118.53 Million		 +99.87%
2020-12-31 Skr551.09 Million
≈ $59.31 Million		 -3.21%
2019-12-31 Skr569.38 Million
≈ $61.27 Million		 +161.41%
2018-12-31 Skr217.81 Million
≈ $23.44 Million		 +87.12%
2017-12-31 Skr116.40 Million
≈ $12.53 Million		 +9123.72%
2016-12-31 Skr1.26 Million
≈ $135.81K		 +181.70%
2015-12-31 Skr448.00K
≈ $48.21K		 --

Equity Component Analysis

This analysis shows how different components contribute to Sedana Medical AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 32664300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock Skr2.48 Million 0.28%
Other Comprehensive Income Skr-3.73 Million -0.41%
Other Components Skr1.23 Billion 136.40%
Total Equity Skr900.78 Million 100.00%

Sedana Medical AB Competitors by Market Cap

The table below lists competitors of Sedana Medical AB ranked by their market capitalization.

Company Market Cap
Se Gyung Hi Tech Co.Ltd
KQ:148150
 $110.33 Million
Nerdy Inc
NYSE:NRDY
 $110.37 Million
SAMYOUNG M-Tek Co. Ltd
KQ:054540
 $110.40 Million
Nova Klúbburinn hf.
IC:NOVA
 $110.40 Million
Eusu Holdings
KO:000700
 $110.30 Million
Merck Tbk
JK:MERK
 $110.25 Million
Crossject
PA:ALCJ
 $110.24 Million
Yuhwa Sec
KO:003460
 $110.23 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Sedana Medical AB's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 958,227,000 to 900,781,000, a change of -57,446,000 (-6.0%).
  • Net loss of 59,244,000 reduced equity.
  • Other comprehensive income increased equity by 60,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income Skr-59.24 Million -6.58%
Other Comprehensive Income Skr60.00K +0.01%
Other Changes Skr1.74 Million +0.19%
Total Change Skr- -6.00%

Book Value vs Market Value Analysis

This analysis compares Sedana Medical AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.14x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has decreased from 1573.11x to 1.14x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2015-12-31 Skr0.01 Skr10.32 x
2016-12-31 Skr0.02 Skr10.32 x
2017-12-31 Skr1.70 Skr10.32 x
2018-12-31 Skr2.84 Skr10.32 x
2019-12-31 Skr6.80 Skr10.32 x
2020-12-31 Skr6.02 Skr10.32 x
2021-12-31 Skr11.87 Skr10.32 x
2022-12-31 Skr10.36 Skr10.32 x
2023-12-31 Skr9.76 Skr10.32 x
2024-12-31 Skr9.65 Skr10.32 x
2025-12-31 Skr9.07 Skr10.32 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Sedana Medical AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -6.58%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -29.59%
  • • Asset Turnover: 0.21x
  • • Equity Multiplier: 1.06x
  • Recent ROE (-6.58%) is above the historical average (-18.87%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2015 -268.97% -4.29% 2.27x 27.68x Skr-1.25 Million
2016 101.90% 4.00% 1.40x 18.15x Skr1.16 Million
2017 -3.33% -9.59% 0.31x 1.13x Skr-15.52 Million
2018 -3.15% -11.86% 0.25x 1.06x Skr-28.65 Million
2019 -2.87% -22.83% 0.12x 1.04x Skr-73.30 Million
2020 -4.92% -19.14% 0.24x 1.09x Skr-82.25 Million
2021 -5.26% -36.42% 0.14x 1.06x Skr-168.11 Million
2022 -7.14% -59.83% 0.11x 1.05x Skr-176.42 Million
2023 -6.15% -38.74% 0.15x 1.05x Skr-156.61 Million
2024 -1.11% -5.97% 0.18x 1.06x Skr-106.50 Million
2025 -6.58% -29.59% 0.21x 1.06x Skr-149.32 Million

Industry Comparison

This section compares Sedana Medical AB's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $171,567,428
  • Average return on equity (ROE) among peers: -27.92%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Sedana Medical AB (SEDANA) Skr900.78 Million -268.97% 0.06x $110.32 Million
Acarix A/S (ACARIX) $15.12 Million -127.02% 0.21x $33.84 Million
Arcoma AB (ARCOMA) $48.66 Million 5.27% 0.68x $11.55 Million
Bactiguard Holding AB (publ) (BACTI-B) $387.11 Million -0.84% 0.62x $61.64 Million
BICO Group AB (BICO) $2.31 Million 0.00% 2.47x $159.82 Million
Boule Diagnostics AB (BOUL) $295.74 Million 7.87% 0.93x $14.38 Million
CellaVision AB (CEVI) $887.58 Million 17.25% 0.23x $311.10 Million
Clinical Laserthermia Systems AB (publ) (CLS-B) $26.09 Million -70.24% 0.12x $11.57 Million
Chordate Medical Holding AB (CMH) $25.64 Million -77.06% 0.22x $29.05K
C-Rad AB (publ) (CRAD-B) $29.82 Million -34.38% 0.50x $86.08 Million
Duearity AB (DEAR) $-2.39 Million 0.00% 0.00x $331.97K

About Sedana Medical AB

ST:SEDANA Sweden Medical Devices
Market Cap
$110.32 Million
Skr1.03 Billion SEK
Market Cap Rank
#18798 Global
#331 in Sweden
Share Price
Skr10.32
Change (1 day)
+0.98%
52-Week Range
Skr8.31 - Skr17.48
All Time High
Skr107.10
Categories
Companies in Sweden Medical Devices
About

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more